As of the latest SEC filings, Neurogene Inc. (NGNE) is held by 125 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $7,704,970.56 in market value, representing a significant portion of its portfolio.
Funds holding Neurogene Inc. (NGNE)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- NGNE
- CIK:
- 0001404644
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $7,704,970.56 | 382,191 | Mar 31, 2026 | May 28, 2026 |
|
FBTIX
Fidelity Advisor Biotechnology Fund
|
MF | Fidelity | 0.33% | $6,358,133.00 | 243,700 | Apr 30, 2026 | Jun 26, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.01% | $5,452,493.76 | 270,461 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.01% | $2,918,949.20 | 111,880 | Apr 30, 2026 | Jun 26, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $2,429,925.12 | 120,532 | Mar 31, 2026 | May 28, 2026 |
|
KOMP
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF
|
ETF | State Street (SPDR) | 0.09% | $2,037,672.00 | 101,075 | Mar 31, 2026 | May 28, 2026 |
|
IWN
iShares Russell 2000 Value ETF
|
ETF | BlackRock / iShares | 0.02% | $1,944,190.08 | 96,438 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.02% | $1,909,031.04 | 94,694 | Mar 31, 2026 | May 28, 2026 |
|
FESM
Fidelity Enhanced Small Cap ETF
|
ETF | Fidelity | 0.04% | $1,569,435.84 | 77,849 | Mar 31, 2026 | May 26, 2026 |
|
MSGAX
Meridian Small Cap Growth Fund
|
MF | Independent / Boutique | 0.65% | $1,529,317.44 | 75,859 | Mar 31, 2026 | Jun 1, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $1,335,523.95 | 56,855 | Feb 28, 2026 | Apr 24, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.02% | $1,200,339.00 | 51,100 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.01% | $1,139,358.96 | 48,504 | Feb 28, 2026 | Apr 28, 2026 |
|
BMEZ
BlackRock Health Sciences Term Trust
|
CEF | BlackRock / iShares | 0.07% | $729,771.84 | 36,199 | Mar 31, 2026 | May 28, 2026 |
|
SWSSX
Schwab Small-Cap Index Fund
|
MF | Charles Schwab | 0.01% | $647,527.71 | 24,819 | Apr 30, 2026 | Jun 25, 2026 |
|
IWC
iShares Micro-Cap ETF
|
ETF | BlackRock / iShares | 0.05% | $573,048.00 | 28,425 | Mar 31, 2026 | May 28, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $441,001.26 | 18,774 | Feb 28, 2026 | Apr 24, 2026 |
|
AVSC
Avantis U.S. Small Cap Equity ETF
|
ETF | American Century | 0.02% | $388,782.99 | 16,551 | Feb 28, 2026 | Apr 29, 2026 |
|
BRSIX
Ultra-Small Company Market Fund
|
MF | Independent / Boutique | 0.31% | $378,624.96 | 18,781 | Mar 31, 2026 | May 21, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $360,031.23 | 15,327 | Feb 28, 2026 | Apr 24, 2026 |
|
BBC
Virtus Biotech Clinical Trials Etf
|
ETF | Independent / Boutique | 0.92% | $344,205.37 | 13,193 | Apr 30, 2026 | Jun 22, 2026 |
|
-
Master Small Cap Index Series
|
ETF | Independent / Boutique | 0.01% | $339,252.48 | 16,828 | Mar 31, 2026 | May 28, 2026 |
|
JSCZX
JPMorgan U.S. Small Company Fund
|
MF | JPMorgan | 0.04% | $334,998.72 | 16,617 | Mar 31, 2026 | May 29, 2026 |
|
SBIO
ALPS Medical Breakthroughs ETF
|
ETF | Independent / Boutique | 0.23% | $324,302.94 | 13,806 | Feb 28, 2026 | Apr 29, 2026 |
|
TRHBX
Nuveen Small Cap Blend Index Fund
|
MF | TIAA / Nuveen | 0.01% | $323,281.19 | 12,391 | Apr 30, 2026 | Jun 24, 2026 |
Advertisement (320x50)